Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Cupid Ltd. Shares Rise 2% as Promoter Buys 4.1 Million Shares; Stock Up 1300%+ in 2 Years

· · 2 min read

Cupid Ltd. shares climbed 2% after Chairman Aditya Kumar Halwasiya acquired 4.1 million shares through open market purchases. This transaction increased his individual stake to 34.23%, signaling strong promoter confidence in the personal care firm's future.

Shares of Cupid Ltd. saw a 2% increase today, reaching Rs 256.50, following an announcement that Aditya Kumar Halwasiya, the company's promoter, Chairman, and Managing Director, purchased 4.1 million shares via open market transactions.

Promoter Confidence Boosts Stake

This significant acquisition raises Mr. Halwasiya's individual stake in Cupid Ltd. from 33.92% to 34.23%. Consequently, the total promoter group ownership of the personal care firm has now reached 47.18%, signaling robust confidence from the company's leadership.

Notably, this is not Mr. Halwasiya's first recent purchase; he also acquired 1.5 million shares through an open market transaction on September 9, further solidifying his position.

Multibagger Returns and Market Position

Cupid Ltd. has been a remarkable performer on the stock market, delivering impressive returns to investors. The stock has surged 210% in the last six months, an astounding 1339% over two years, and an even more exceptional 6193% over the past three years. The company currently boasts a market capitalization of Rs 34,147 crore.

Despite its rapid growth, technical indicators suggest the stock is neither overbought nor oversold, with a Relative Strength Index (RSI) of 36.8. While trading below its 5, 10, 20, 30, and 50-day moving averages, Cupid Ltd. shares remain above their 100, 150, and 200-day moving averages, indicating underlying long-term strength.

About Cupid Ltd.

Cupid Ltd. specializes in the manufacturing and marketing of male and female condoms, water-based personal lubricants, and in-vitro diagnostic (IVD) kits. The company also maintains a diverse portfolio of Consumer Healthcare and Fast-Moving Consumer Goods (FMCG) products, catering to a broad market within the personal care and health sectors.

Related